Every parliamentary written question tabled by Ben Obese-Jecty this session, with the full answer and department. Back to the MP page.
Showing 1–20 of 246 · Department for Science, Innovation and Technology
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress has she made in applying only validated alternative methods to satisfy UK regulatory requirements for skin irritation testing.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress has she made in replacing animal use in skin sensitisation testing.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress has she made in replacing animals used for eye irritation testing and applying only validated alternative methods to satisfy UK regulatory requirements for eye irritation testing.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, by when does she plan to host an international meeting of regulators in the UK on the validation and acceptance of alternative models.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress has she made in applying only validated alternative methods to satisfy UK regulatory requirements for skin sensitisation testing.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, by what date she plans to publish the UK alternative method priorities list.
Awaiting answer.
Innovation and Technology, with reference to the National Security Strategy 2025: Security for the British People in a Dangerous World (CP1338), published on 24 June 2025, what progress has she made in enhancing collaboration with Canada on nuclear fusion.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress has she made in replacing in vivo skin irritation testing.
Awaiting answer.
Innovation and Technology, with reference to the fourth report of the Joint Committee on the National Security Strategy (CP1338), published on 24 June 2025, what progress has he made in bringing new creativity to UK international partnerships in technology.
Awaiting answer.
Innovation and Technology, pursuant to the answer of 16 April 2026 to question 126825 on Animal Experiments, by what date in 2026 does she plan to publish a delivery update.
Awaiting answer.
Innovation and Technology, pursuant to the answer of 16 April 2026 to question 126825 on Animal Experiments, what progress has she made regarding reform of the Medicines and Healthcare products Regulatory Agency.
Awaiting answer.
Innovation and Technology, with reference to the Answer of 16 April 2026 to question 126825 on Animal Experiments, with which countries is she currently scoping opportunities for international engagement at a) multilateral and b) bilateral level.
Awaiting answer.
Innovation and Technology, which projects are being delivered by the Advanced Research and Invention Agency.
Awaiting answer.
Innovation and Technology, what is the scope of Project REFLECT under the Advanced Research and Invention Agency.
Awaiting answer.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made in reducing animal use in cardiovascular safety studies.
Basket 2 of the strategy outlines long‑term ambitions which must be science‑led, partnership‑based, and delivered over time.Innovate UK in partnership with NC3Rs launched a funding call supporting the development and commercialisation of alternative methods for assessing the preclinical cardiovascular safety of new medicines: Contracts for Innovation: industrial human relevant drug models – UKRI. This follows work led by IUK and NC3Rs to build a community around this opportunity. https://www.ukri.org/opportunity/contracts-for-innovation-industrial-human-relevant-drug-models/The strategy aims to use validated alternative methods to reduce the use of non‑human primates and dogs in dedicated cardiovascular safety studies by at least 50% by 2030.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress her Department has made in (a) developing AI prediction tools and (b) obtaining kinetic data from combining tests with general toxicity testing.
This is an area of extensive effort across industry and stakeholders. NC3Rs are funding development of a virtual dog to replace dogs in second species testing (Virtual Second Species Innovation Platform). We continue working with partners to develop resources to expand these efforts.The strategy has not committed to obtaining kinetic data. Basket 2 sets out long‑term ambitions that must be science‑led, partnership‑based and delivered over time.The strategy aims to use validated alternative methods to reduce use of dogs and non‑human primates in dedicated Pharmacokinetic studies for human medicines by at least 35% by 2030.
With reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress he has made in replacing adventitious agent testing in animals.
I refer the Hon. Member to the answer I gave on 28 April 2026 to Question 128366.
Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on collecting data annually on the number of clinical trial applications that include toxicity tests conducted in 2 species.
I refer the hon. Member to the answer given on 20th April to Question UIN 125672.
Innovation and Technology, with reference to her Department's policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made in obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.
The strategy has not committed to obtaining the full validation of the Comprehensive in vitro Proarrhythmia Assay (CiPA) initiative to predict the proarrhythmic potential of new drugs.Basket 2 of the strategy outlines long‑term ambitions which must be science‑led, partnership‑based, and delivered over time.The strategy aims to use validated alternative methods to reduce the use of dogs and non-human primates in dedicated Pharmacokinetic studies for human medicines by at least 35% by 2030.
Innovation and Technology, with reference to the policy paper entitled Replacing animals in science: A strategy to support the development, validation and uptake of alternative methods, published on 11 November 2025, what progress she has made on restarting the survey on public attitudes to animal research.
A competition has been launched to secure support in delivering the next waves of the survey on public attitudes to animal research. Feedback from key stakeholders has been sought on the survey questions from the last wave.